Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320921208> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W4320921208 endingPage "176" @default.
- W4320921208 startingPage "171" @default.
- W4320921208 abstract "ASP8062 is an orally available GABAB receptor positive allosteric modulator (PAM). This study assessed the potential of ASP8062 for treating opioid use disorder (OUD). Three rhesus monkeys were pretreated with ASP8062 (0.3, 1 or 3 mg/kg) by oral administration 1 h prior to a 2-h morphine self-administration session (0.03 mg/kg, iv, per injection) under a fixed-ratio 5 schedule. We further examined the potential worsening of morphine-induced respiratory suppression by ASP8062 after coadministration of morphine (10 mg/kg, sc) and ASP8062 (10 mg/kg, po) in cynomolgus monkeys using a custom-made whole-body plethysmograph. Plasma concentrations of ASP8062 (3 or 10 mg/kg, po) were assessed in cynomolgus monkeys using liquid chromatography-tandem mass spectroscopy (LC-MS/MS). ASP8062 at 3 mg/kg, po decreased the morphine self-administrations with significant differences from the vehicle-treated group (IC50 = 0.97 ± 0.36 mg/kg). Exposure levels at 3 mg/kg observed in monkeys were comparable to the clinical exposure levels which positive pharmacodynamic effects were previously shown. Further, ASP8062 did not potentiate morphine-induced respiratory suppression up to exposure levels higher than the clinically relevant dose. ASP8062 may reduce opioid use in OUD patients without affecting respiratory system, providing justification for further ASP8062 development as a potential treatment option for OUD." @default.
- W4320921208 created "2023-02-16" @default.
- W4320921208 creator A5034279853 @default.
- W4320921208 creator A5058972665 @default.
- W4320921208 creator A5062171111 @default.
- W4320921208 creator A5066138488 @default.
- W4320921208 creator A5086384891 @default.
- W4320921208 date "2023-04-01" @default.
- W4320921208 modified "2023-09-25" @default.
- W4320921208 title "Effect of ASP8062 on morphine self-administration and morphine-induced respiratory suppression in monkeys" @default.
- W4320921208 cites W1982312755 @default.
- W4320921208 cites W1983696090 @default.
- W4320921208 cites W1989993438 @default.
- W4320921208 cites W1996447318 @default.
- W4320921208 cites W2019187900 @default.
- W4320921208 cites W2021123813 @default.
- W4320921208 cites W2065526527 @default.
- W4320921208 cites W2074214484 @default.
- W4320921208 cites W2086793032 @default.
- W4320921208 cites W2090850294 @default.
- W4320921208 cites W2091192459 @default.
- W4320921208 cites W2104314642 @default.
- W4320921208 cites W2115378219 @default.
- W4320921208 cites W2134458339 @default.
- W4320921208 cites W2157230965 @default.
- W4320921208 cites W2172137255 @default.
- W4320921208 cites W2904830602 @default.
- W4320921208 cites W2912153459 @default.
- W4320921208 cites W2921255665 @default.
- W4320921208 cites W2964762887 @default.
- W4320921208 cites W2982110959 @default.
- W4320921208 cites W2989764680 @default.
- W4320921208 cites W2998813706 @default.
- W4320921208 cites W3000475066 @default.
- W4320921208 cites W3092068166 @default.
- W4320921208 cites W3119480574 @default.
- W4320921208 cites W4220810447 @default.
- W4320921208 doi "https://doi.org/10.1016/j.jphs.2023.02.003" @default.
- W4320921208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36925215" @default.
- W4320921208 hasPublicationYear "2023" @default.
- W4320921208 type Work @default.
- W4320921208 citedByCount "1" @default.
- W4320921208 countsByYear W43209212082023 @default.
- W4320921208 crossrefType "journal-article" @default.
- W4320921208 hasAuthorship W4320921208A5034279853 @default.
- W4320921208 hasAuthorship W4320921208A5058972665 @default.
- W4320921208 hasAuthorship W4320921208A5062171111 @default.
- W4320921208 hasAuthorship W4320921208A5066138488 @default.
- W4320921208 hasAuthorship W4320921208A5086384891 @default.
- W4320921208 hasBestOaLocation W43209212081 @default.
- W4320921208 hasConcept C111113717 @default.
- W4320921208 hasConcept C112705442 @default.
- W4320921208 hasConcept C126322002 @default.
- W4320921208 hasConcept C170493617 @default.
- W4320921208 hasConcept C2777389121 @default.
- W4320921208 hasConcept C2778555786 @default.
- W4320921208 hasConcept C2781063702 @default.
- W4320921208 hasConcept C42219234 @default.
- W4320921208 hasConcept C534529494 @default.
- W4320921208 hasConcept C71924100 @default.
- W4320921208 hasConcept C98274493 @default.
- W4320921208 hasConceptScore W4320921208C111113717 @default.
- W4320921208 hasConceptScore W4320921208C112705442 @default.
- W4320921208 hasConceptScore W4320921208C126322002 @default.
- W4320921208 hasConceptScore W4320921208C170493617 @default.
- W4320921208 hasConceptScore W4320921208C2777389121 @default.
- W4320921208 hasConceptScore W4320921208C2778555786 @default.
- W4320921208 hasConceptScore W4320921208C2781063702 @default.
- W4320921208 hasConceptScore W4320921208C42219234 @default.
- W4320921208 hasConceptScore W4320921208C534529494 @default.
- W4320921208 hasConceptScore W4320921208C71924100 @default.
- W4320921208 hasConceptScore W4320921208C98274493 @default.
- W4320921208 hasIssue "4" @default.
- W4320921208 hasLocation W43209212081 @default.
- W4320921208 hasLocation W43209212082 @default.
- W4320921208 hasOpenAccess W4320921208 @default.
- W4320921208 hasPrimaryLocation W43209212081 @default.
- W4320921208 hasRelatedWork W1975707813 @default.
- W4320921208 hasRelatedWork W1979089754 @default.
- W4320921208 hasRelatedWork W2005929448 @default.
- W4320921208 hasRelatedWork W2013286654 @default.
- W4320921208 hasRelatedWork W2062935199 @default.
- W4320921208 hasRelatedWork W2111569334 @default.
- W4320921208 hasRelatedWork W3098689426 @default.
- W4320921208 hasRelatedWork W4200176212 @default.
- W4320921208 hasRelatedWork W4206871862 @default.
- W4320921208 hasRelatedWork W4287435042 @default.
- W4320921208 hasVolume "151" @default.
- W4320921208 isParatext "false" @default.
- W4320921208 isRetracted "false" @default.
- W4320921208 workType "article" @default.